Skip to content
Review Open access

Neuropathic Pain: From Mechanisms to Therapeutic Interventions

Oct 2026 · MedComm · Vol 7 · 0 citations · 182 references
Medicine

TL;DR

Key clinical dimensions, including sensory gain, sensory loss, peripheral and central pain generators, mixed nociceptive‐neuropathic pain, central sensitization, and autonomic or small‐fiber modifiers are described, which support a shift from symptom‐based assessment to mechanism‐guided precision care for neuropathic pain.

Abstract

Neuropathic pain is caused by injury or disease of the somatosensory system. It involves peripheral nerve injury, central sensitization, transmitter imbalance, glial activation, and large‐scale network remodeling. Despite substantial advances in pain biology, clinical assessment continues to rely predominantly on patient‐reported symptoms, sensory examination, and conventional neurophysiological testing, approaches that often fail to delineate the predominant biological mechanisms underlying pain in individual patients. Recent advances in sensory phenotyping and multimodal imaging have enabled in vivo characterization of abnormalities at the receptor, neuroinflammatory, and circuit levels, thereby providing a foundation for mechanism‐based stratification and more individualized therapeutic decision‐making. This review summarizes neuropathic pain from clinical stratification to mechanism‐based imaging and therapeutic intervention. We describe key clinical dimensions, including sensory gain, sensory loss, peripheral and central pain generators, mixed nociceptive‐neuropathic pain, central sensitization, and autonomic or small‐fiber modifiers. These dimensions help explain why patients with the same diagnosis may show different symptoms and treatment responses. We also review major molecular mechanisms, including glutamatergic overactivity, GABAergic and glycinergic disinhibition, monoaminergic remodeling, and neuroimmune modulation. These changes reshape spinal, thalamocortical, limbic, salience, reward, cerebellar, and descending control circuits. Peripheral nerve ultrasound and MR neurography can help identify structural peripheral pain generators. PET, MRS, MRI, DTI, fMRI, EEG, and multimodal imaging can assess receptor availability, neurotransmitter balance, neuroinflammation, white matter integrity, and network connectivity. These imaging tools may link clinical phenotypes with biological mechanisms and help define mechanism‐based subtypes. Imaging biomarkers may also support treatment selection, treatment monitoring, neuromodulation targeting, and translational trial design. This framework supports a shift from symptom‐based assessment to mechanism‐guided precision care for neuropathic pain.

Read PDF

Similar papers

Review Open access Sep 2026

Emerging pharmacological strategies for neuropathic pain: Mechanism-based targeting and precision medicine

Neuropathic pain (NP) is a type of chronic pain syndrome due to structural or functional alterations in the somatosensory nervous system after injury, including long-lasting painful sensations and allodynia and hyperalgesia. Due to its intricate pathophysiology and significant interindividual variation in therapeutic r...

Rui Zhao · 0 citations
Review Open access Sep 2026

Neuroplastic mechanisms of chronic pain: Implications and future directions

Chronic pain is now increasingly viewed as aberrant neuroplasticity rather than a protracted expression of peripheral nociception. This review integrates current knowledge through the lens of a peripheral-to-central paradigm, whereby peripheral sensory sensitization contributes to pain initiation, spinal excitation–inh...

Kai-Kai Wang, Yan-Hui He, Jin-Hai Liu et al. · 0 citations
Review Open access Oct 2026

NEUROPHYSIOLOGICAL MECHANISMS AND PHYSIOTHERAPEUTIC STRATEGIES IN THE MANAGEMENT OF CHRONIC NEUROPATHIC PAIN: EMERGING CLINICAL EVIDENCE

Chronic neuropathic pain is a complex, disabling condition that is caused by lesions or diseases of the somatosensory nervous system. It is sustained by peripheral nerve dysfunction, ectopic activity, dysregulated ion channels, neuroimmune dysfunction, central sensitization, maladaptive brain network function and neuro...

S. Raman, S. Kumar, Deepika Saroha et al. · 0 citations
Review Open access Nov 2026

Spontaneous neuropathic pain

Abstract Spontaneous pain is a highly prevalent and disabling consequence of neuropathic disorders, yet it remains mechanistically underdefined and therapeutically underserved. Historically, preclinical animal models and clinical trials have been overwhelmingly biased toward stimulus-evoked hypersensitivity, relegating...

Xiangsunze Zeng, C. Woolf · 0 citations
Review Open access Sep 2026

Spinal cord stimulation in the treatment of chronic pain: from evidence to clinical practice - part 1.

INTRODUCTION Neuropathic pain is caused by a lesion or disease of the somatosensory nervous system. Pharmacotherapy remains the primary treatment for this condition, although non-pharmacological modalities such as physical and psychological therapy are also recommended. STATE OF THE ART Due to the limited efficacy of...

T. Mandat, K. Kotfis, Paweł Sokal et al. · 0 citations
Review Open access Sep 2026

Neural Mechanisms and Brain Alterations in Orofacial Pain: A Narrative Review of Human Neuroimaging

Findings support the involvement of distributed neural mechanisms and neuroplastic changes in many chronic orofacial pain conditions, while emphasizing that peripheral, central, psychosocial, and contextual factors may contribute to varying degrees across disorders and individuals.

Nelson Freitas, C. Faria, D. Pozza · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.